Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohort.

Fuente: Zenodo
Saved in:
Bibliographic Details
Main Authors: Constantine A, Dimopoulos K, Condliffe R, Clift P, Jansen K, Wort SJ, Chaplin G, Krishnathasan K, Dhillon R, Mookerjee J, Knight WB, Jones CB, Forte MNV, Wilson D, Michael H, Soto AM, Labrandero C, Ogando AR, Galdó AM, Rodríguez IG, Cuenca LMC, Perin F, Bonora AM, Ramón ML, Albert SV, Riezu MÁI, López JME, Del Cerro Marín MJ, Moledina S
Format: Recurso digital
Language:English
Published: Zenodo 2026
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866902172644409344
author Constantine A
Dimopoulos K
Condliffe R
Clift P
Jansen K
Wort SJ
Chaplin G
Krishnathasan K
Dhillon R
Mookerjee J
Knight WB
Jones CB
Forte MNV
Wilson D
Michael H
Soto AM
Labrandero C
Ogando AR
Galdó AM
Rodríguez IG
Cuenca LMC
Perin F
Bonora AM
Ramón ML
Albert SV
Riezu MÁI
López JME
Del Cerro Marín MJ
Moledina S
author_facet Constantine A
Dimopoulos K
Condliffe R
Clift P
Jansen K
Wort SJ
Chaplin G
Krishnathasan K
Dhillon R
Mookerjee J
Knight WB
Jones CB
Forte MNV
Wilson D
Michael H
Soto AM
Labrandero C
Ogando AR
Galdó AM
Rodríguez IG
Cuenca LMC
Perin F
Bonora AM
Ramón ML
Albert SV
Riezu MÁI
López JME
Del Cerro Marín MJ
Moledina S
contents BACKGROUND AND AIMS: Pulmonary arterial hypertension (PAH) is a common complication of congenital heart disease (CHD). PAH following CHD repair (repaired PAH-CHD) is an emerging population with increased morbidity and mortality. Existing PAH risk scores are unvalidated in young children with this condition. METHODS: A 20-year cohort from the UK National Paediatric PH Service was studied to describe peri-operative characteristics and outcomes in children with repaired PAH-CHD and to create a tailored risk stratification tool. This tool was externally validated using the national Spanish PH (REHIPED) registry. RESULTS: The study included 178 patients (median age 3.2 years, 58.4% female), with 73.0% referred post-CHD repair. Complex CHD was present in 61.2%, and 48.9% had both pre- and post-tricuspid shunts. Down syndrome was noted in 33.1%. At initial post-operative assessment, 53.1% exhibited symptoms like breathlessness, 30.9% had moderate-severe right ventricular dilatation, and 23.7% showed right ventricular systolic impairment. During a median six-year follow-up of 156 patients, 19.2% died and 3.2% required lung transplantation, with survival rates at one, five, and ten years being 94.7%, 85.9%, and 80.1%, respectively. The developed risk score, based on clinical variables including absence of pre-operative PH, breathlessness, right ventricular dysfunction, and pulmonary vascular resistance index, showed good performance and calibration in predicting outcomes. CONCLUSIONS: In this national cohort of children with repaired PAH-CHD, mortality is significant. This novel, simple risk score has been developed and validated specifically for children with repaired PAH-CHD, useful at the time of post-operative assessment to predict outcome and direct management. © The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
format Recurso digital
id zenodo_https___doi_org_10_1093_ehjqcco_qcaf150
institution Zenodo
language eng
publishDate 2026
publisher Zenodo
record_format zenodo
spellingShingle Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohort.
Constantine A
Dimopoulos K
Condliffe R
Clift P
Jansen K
Wort SJ
Chaplin G
Krishnathasan K
Dhillon R
Mookerjee J
Knight WB
Jones CB
Forte MNV
Wilson D
Michael H
Soto AM
Labrandero C
Ogando AR
Galdó AM
Rodríguez IG
Cuenca LMC
Perin F
Bonora AM
Ramón ML
Albert SV
Riezu MÁI
López JME
Del Cerro Marín MJ
Moledina S
Paediatric cardiology
external validation
observational study
pulmonary hypertension
risk score development
BACKGROUND AND AIMS: Pulmonary arterial hypertension (PAH) is a common complication of congenital heart disease (CHD). PAH following CHD repair (repaired PAH-CHD) is an emerging population with increased morbidity and mortality. Existing PAH risk scores are unvalidated in young children with this condition. METHODS: A 20-year cohort from the UK National Paediatric PH Service was studied to describe peri-operative characteristics and outcomes in children with repaired PAH-CHD and to create a tailored risk stratification tool. This tool was externally validated using the national Spanish PH (REHIPED) registry. RESULTS: The study included 178 patients (median age 3.2 years, 58.4% female), with 73.0% referred post-CHD repair. Complex CHD was present in 61.2%, and 48.9% had both pre- and post-tricuspid shunts. Down syndrome was noted in 33.1%. At initial post-operative assessment, 53.1% exhibited symptoms like breathlessness, 30.9% had moderate-severe right ventricular dilatation, and 23.7% showed right ventricular systolic impairment. During a median six-year follow-up of 156 patients, 19.2% died and 3.2% required lung transplantation, with survival rates at one, five, and ten years being 94.7%, 85.9%, and 80.1%, respectively. The developed risk score, based on clinical variables including absence of pre-operative PH, breathlessness, right ventricular dysfunction, and pulmonary vascular resistance index, showed good performance and calibration in predicting outcomes. CONCLUSIONS: In this national cohort of children with repaired PAH-CHD, mortality is significant. This novel, simple risk score has been developed and validated specifically for children with repaired PAH-CHD, useful at the time of post-operative assessment to predict outcome and direct management. © The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
title Paediatric pulmonary arterial hypertension following congenital heart defect repair: Enhanced risk stratification and outcomes in a national cohort.
topic Paediatric cardiology
external validation
observational study
pulmonary hypertension
risk score development
url https://doi.org/10.1093/ehjqcco/qcaf150